Citizen Petition from Alexander Mauskop
Details
The document's own metadata, straight from the source system.
- Title
- Citizen Petition from Alexander Mauskop
- Posted
- Jan 30, 2026
- Comment period
- Jan 30, 2026 – ?
- Topics
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Stance breakdown
Who commented
Breakdown by commenter type.
Comments over time
Weekly arrivals, stacked by stance.
Support × commenter type
How each type splits across stance.
Issues raised
The docket's canonical issues. Select one to browse its comments.
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
- Jul 15, 2026Comment from Coleen PfeuferOpposeIndividualRead comment →
- Jul 8, 2026Comment from Deborah ESupportIndividual
Alexander Mauskop supports making triptans available over-the-counter (OTC) to reduce healthcare costs and improve patient access. He argues that the current prescription-only model creates unnecessary barriers and cites successful precedents in European countries.
Read comment → - Jul 2, 2026Comment from Beth FishmanSupportIndividualRead comment →
- Jun 26, 2026Comment from Hanna FeibusSupportIndividualRead comment →
- Jun 17, 2026Comment from Julie KohnSupportIndividualRead comment →
- Jun 10, 2026Comment from Danielle FSupportIndividualRead comment →
- Jun 10, 2026Comment from AnonymousSupportIndividualRead comment →
- Jun 6, 2026Comment from Isaac EstermanSupportIndividual
A private individual who suffers from cluster headaches argues in favor of making triptans available over the counter. The commenter notes that triptans are effective for severe pain with minimal side effects and low potential for abuse, suggesting that OTC availability would help those without easy access to prescriptions.
Read comment → - Jun 1, 2026Comment from Michelle NakashSupportIndividual
The commenter, a private individual suffering from chronic migraines, supports making triptans available over the counter in the United States. They argue that this change would improve access to treatment for common neurological conditions, especially for those facing long wait times for specialist appointments.
Read comment → - May 31, 2026Comment from Nathaniel ZieringSupportIndividual
The commenter, a private individual, argues that the current insurance coverage for triptans is insufficient for those with frequent migraines. They advocate for making generic triptans available over-the-counter to address a growing public health emergency exacerbated by climate change and pollution.
Read comment →
